Form 4 for TDOC Teladoc Health, Inc.
Accepted 2026-06-03 16:25:18 ET · period of report 2026-06-01 · accession 0001375088-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-06-03 16:25 | 2026-06-01 | TDOC | Vandervoort Adam C | CLO, Sec | M - OptEx | — | +14.9K | 118.2K | +14% | — |
| D | 2026-06-03 16:25 | 2026-06-02 | TDOC | Vandervoort Adam C | CLO, Sec | S - Sale+OE | $7.63 | -7,906 | 110.3K | -7% | -$60.3K |
| DM | 2026-06-03 16:25 | 2026-06-01 | TDOC | Vandervoort Adam C | CLO, Sec | M - OptEx | $0.00 | -14.9K | 64.1K | -19% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-01 | M | A | 426 | — | 103,665 | D | — | — | (F1) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2026-06-01 | M | A | 5,350 | — | 109,015 | D | — | — | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 3 | Common | Common Stock | 2026-06-01 | M | A | 9,152 | — | 118,167 | D | — | — | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 4 | Common | Common Stock | 2026-06-02 | S | D | 7,906 | $7.63 | 110,261 | D | — | — | (F3) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| 5 | Derivative | Performance Stock Units | 2026-06-01 | M | D | 426 | $0.00 | 2,979 | D | — · — to — | 426 Common Stock | (F1) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. (F4) The performance stock units vest as to one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. (F4) The performance stock units vest as to one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. (F5) On March 1, 2026, the reporting person earned 5,107 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 6 | Derivative | Restricted Stock Units | 2026-06-01 | M | D | 5,350 | $0.00 | 16,050 | D | — · — to — | 5,350 Common Stock | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F6) On March 19, 2024, the reporting person was granted 64,200 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. (F6) On March 19, 2024, the reporting person was granted 64,200 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. |
| 7 | Derivative | Restricted Stock Units | 2026-06-01 | M | D | 9,152 | $0.00 | 64,070 | D | — · — to — | 9,152 Common Stock | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F7) On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. (F7) On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. |